CPIG
AST.WS

Chicago Partners Investment Group’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

Chicago Partners Investment Group’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3
Closed – – 860
2017
Q1 		$0 Hold
3
– – ﹤0.01% 624
2016
Q4 		$0 Hold
3
– – ﹤0.01% 579
2016
Q3 		$0 Hold
3
– – ﹤0.01% 513
2016
Q2 		$0 Buy
+3
New +$2 ﹤0.01% 469

Other funds holding AST.WS

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Chicago Partners Investment Group's AST.WS Position: Q2 2017 in Review

Chicago Partners Investment Group sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q2 2017, closing a stake of 3 shares.

Chicago Partners Investment Group first reported a position in AST.WS in Q2 2016 and held it in 4 quarters. The position peaked at $0 in Q1 2017. 33 funds tracked by Wall St. Rank hold AST.WS as of Q2 2017.

  • Chicago Partners Investment Group reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q2 2017 after selling out during the quarter.
  • Chicago Partners Investment Group sold 3 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q2 2017.
  • Chicago Partners Investment Group first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 4 quarters.
  • Chicago Partners Investment Group's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $0 in Q1 2017.
  • 33 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q2 2017.

Based on Chicago Partners Investment Group's 13F filing for Q2 2017, filed 31 Jul 2017.